Advances in Preventive Medicine
Volume 2020 (2020), Article ID 1603518, 7 pages
https://doi.org/10.1155/2020/1603518

Research Article

Determinants of Noncompletion of the Third Dose of Tetanus Toxoid Vaccine in Pregnant Women in Dschang Health District, Cameroon

Florent Ymele Fouelifack,1,2,3 Bruno Kenfack,4,5 Skinner Lekelem Nguefack,1,4 Jackson Jr Nforbewing Ndenkeh,⁶ Jeanne Hortence Fouedjio,2,7 Loic Dongmo Fouelifa,8,9 and Pierre Marie Tebeu¹⁰

¹Institute of Medical Technology of Nkolondom, Yaoundé, Cameroon
²Obstetrics and Gynecology Unit of Yaoundé Central Hospital, Yaoundé, Cameroon
³Research Education and Health Associative Group GARES-Falaise, Dschang, Cameroon
⁴Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon
⁵Obstetrics and Gynecology Unit of District Hospital, Dschang, Cameroon
⁶Center of International Health, Ludwig Maximilian University of Munich, Munich, Germany
⁷Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon
⁸Faculty of Health Sciences, University of Lomé, Lomé, Togo
⁹School of Armies Health Services of Lomé, Lomé, Togo
¹⁰Centre Inter‐Etats d’Enseignement Supérieur en Sante Publique d’Afrique (CIESPA), Brazzaville, Congo

Correspondence should be addressed to Florent Ymele Fouelifack; yfouelifack@gmail.com

Received 18 June 2019; Accepted 13 November 2019; Published 25 February 2020

Academic Editor: Diego A. S. Silva

Copyright © 2020 Florent Ymele Fouelifack et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Introduction. Tetanus vaccination plays an important role in the fight against neonatal mortality. Our study aimed to determine the noncompletion rate of the 3rd dose of tetanus toxoid vaccine (TTV) and to analyze the associated factors in pregnant women. Methods. This was a cross-sectional study conducted in 2 hospitals of Dschang Health District and targeting all women at least in their second gestation coming for antenatal consultation. Upon informed consent by the participant, a prepared questionnaire was administered. The collected data was analyzed using SPSS v22.0 with results presented in means and proportions. Logistic regression was used at two levels to identify independently associated factors for noncompletion of the third dose of TTV with a significance set at 5%. Results. A total of 380 pregnant women were recruited in this study of mean age 27 ± 5.2 yrs, 70% being married, more than 80% having at least secondary education, and 31.8% of them being students. It was noted that 172 (45.26%) of these women had not received the third dose of TTV. The analysis of the adjusted effects showed that not going to postnatal consultation (aOR = 6.75; 3.98–11.49, ), not accompanying her baby to vaccination (aOR = 3.784; 1.803–7.942, ), and being single (aOR = 1.87; 1.05–3.3, ) were independently associated with the above noncompletion rate. Conclusion. Tetanus vaccination coverage is not yet optimal in Dschang Health District and is associated with marital status as well as postgestational behavior of the mothers. There is thus the need to put in place strategies that will provide social support to single mothers as well as encourage women to attend postnatal consultation and to accompany their own children for vaccination. Furthermore, community-based vaccination could capture some of the lost women thus optimizing the overall vaccination coverage.

1. Introduction

Tetanus is a life-threatening disease that mostly affects low-income countries and populations with limited or no access to health services [1]. Every year around the world, tetanus is responsible for more than 450,000 child deaths in the first month of life and more than 40,000 mothers contract this infection during delivery [2]. Many authors found factors related to women, accessibility, organization of immunization services, and the technical skills of health care workers that influence the completion of tetanus vaccination in pregnant women [1, 3]. Implementation of tetanus prevention strategy based mainly on tetanus toxoid vaccination in pregnant women has reduced the number of deaths due to neonatal tetanus worldwide by 93%, from 787,000 cases in 1988 to 58,000 cases in 2010 [2]. Immunization coverage against tetanus remains low in many African countries, notably in Benin where the coverage rate in the second dose of tetanus toxoid vaccine (TTV) was 60% within the last five years, lower than the national objective of 86% [4].

In Cameroon, there is low coverage of TTV in pregnant women. According to the 4th Cameroon Demographic Health Survey back in 2011, 59% of women received at least two doses of TTV during their last pregnancy giving a 41% noncompletion rate of the 2nd dose of TTV [5]. On the other hand, a study showed an incidence of a neonatal tetanus case for every 1000 live births within 2015 in the country [6]. With 118 cases of maternal or neonatal tetanus identified in 2015, it is worth noting that tetanus toxoid vaccination coverage that same year was 62% which was below optimal. The proposition of appropriate strategies to reduce TTV noncompletion rate would contribute to the elimination of maternal and neonatal tetanus in Cameroon [6] and therefore play a role in the achievement of the third sustainable development goal. In order to propose appropriate strategies to strengthen and improve the current vaccination coverage, there is need to understand the underlying factors of noncompletion. This study was thus implemented with the overall objective to appreciate the TTV coverage in Dschang Health District while determining the factors associated with noncompletion of the third dose of TTV.

2. Materials and Methods

2.1. Study Design, Time Period, and Place of Study

The study was a cross-sectional conducted in 2018 targeting pregnant women coming for antenatal consultation. Two hospitals were selected from Dschang Health District found in the West region of Cameroon, namely, the District Hospital of Dschang and “Saint Vincent de Paul” Hospital. Data collection in these hospitals lasted a month (the whole of February 2018). The above hospitals were chosen as the most frequented in the city of Dschang in terms of antenatal consultation and vaccination. They received daily about 15 and 12 women from different sociocultural backgrounds for antenatal consultation, respectively.

2.2. Sampling and Procedure

Sample size for this study was calculated using the following formula which gave 384:

where Z = Z-value which is 1.96,  = anticipated proportion of pregnant women who have not received the 3rd dose of TTV in Cameroon (=50% if unknown),  = 1−, and α = significance level set at 5%.

Notwithstanding, with the exhaustive sampling method within allocated time period for data collection, 380 pregnant women who were at least in their second gestation consented to participate in the study. All nulliparous women as well as women who did not consent to participate in the study were excluded. For each participant upon informed consent, a prepared questionnaire was administered which gathered information on their sociodemographic characteristics, knowledge on, and behavior related to tetanus prevention, etc. The dependent variable here was noncompletion of the third dose of TTV, and the tested independent variables included sociodemographic, economic, medical, and obstetrical characteristics of the participants.

2.3. Data Analysis

All the data collected were keyed in a data entry spreadsheet using Microsoft Excel 2010 software and analyzed using the software SPSS v22.0. The descriptive results were presented in means and proportions for continuous and categorical variables, respectively. Bivariate logistic regression was used to identify potential associated factors which were adjusted for each other’s effect in a multivariate analysis with a significance set at 5%.

2.4. Ethical Considerations

Ethical clearance no. 1552 CEI-UDo/04/2018/T was obtained from the Ethical Committee of the University of Douala/Faculty of Medicine and Pharmaceutical Sciences. Administrative authorizations were also obtained from the directors of both hospitals prior to the start of study. Furthermore, each participant voluntarily consented before being included in the study while all information obtained was treated with respect of confidentiality. For minors, in addition to parent consent, it was required they too provided their assent before being included in the study.

3. Results

In total, 380 participants were included in this study with 188 (49.47%) and 192 (50.52%) recruited from Dschang District Hospital and St. Vincent Hospital, respectively. This study population had age ranging from 17 to 40 yrs with mean age being 27 ± 5.2 yrs and majority fell in the age group 20–35 yrs (Table 1). More than half of the women were workers in public or private sectors, more than three quarters were at least having secondary education, and more than two thirds were married. Overall, it was noted that 17 (4.5%) of the participants had never received tetanus vaccine before. Furthermore, it is worth noting that only 208 (54.74%) had received the third dose, giving a TTV noncompletion rate of 45.26%.

Table 1: Sociodemographic and obstetrical characteristics of participants according to the number of doses of TTV.

Variables
Number of doses of TTV
OR (95% CI)
value

<three doses
≥three doses
Total

N = 172
N = 208
N = 380

n
%
n
%
n
%

Age (mean ± SD)
26.17 ± 4.85 yrs
28.79 ± 5.26 yrs
27 ± 5.2 yrs

Age groups

0.005

17–19
8
4.7
5
2.3
13
3.4
3.07 (0.78–11.49)

20–25
81
47.1
65
31.3
146
38.4
2.28 (1.11–5.15)

26–35
71
41.2
115
55.3
186
48.9
1.98 (0.62–6.75)

35 and above
12
7
23
11.1
35
9.3
1

Health facilities

0,014

District hospital
97
51.6
91
48.4
188
49.47
1.66 (1.11–2.49)

St. Vincent hospital
75
39.06
117
60.94
192
50.52
1

Profession

0.278

Housewife
18
10.5
25
12.0
43
11.3
1.49 (0.64–3.47)

Student
62
36.0
59
28.4
121
31.8
2.17 (1.08–4.34)

Private/public salary earner
92
53.5
124
59.6
216
56.8
1

Level of education

0.676

Primary
29
16.8
30
14.4
59
15.5
1.25 (0.71–2.46)

Secondary
93
54.1
110
52.9
203
53.4
1.14 (0.72–1.81)

Higher
50
29.1
68
32.7
118
31.1
1

Marital status

0,002

Single
69
40.1
45
21.6
114
30.0
2.43 (1.54–3.84)

Married
103
59.9
163
78.4
266
70.0
1

Parity

<0.0001

Paucipara
94
54.6
71
34.1
165
43.4
2.2 (1.11–3.36)

Multipara
66
38.4
117
56.3
183
48.2
1.23 (0.78–2.23)

Grand multipara
12
7
20
9.6
32
8.4
1

Number of antenatal consultations during the last pregnancy

<0.0001

≤2
35
79.54
9
20.45
44
11.57
5,64 (2,63–12,12)

≥3
137
40.77
199
59.22
336
88.42
1

Health facility where antenatal consultation was done

<0.0001

Integrated health center
11
68.75
5
31.25
16
4.21
2.48 (0.82–7.69)

Private health center
25
71.42
10
28.57
35
9.21
2.82 (1.27–6.25)

District hospital
77
47.23
86
52.77
163
42.89
1.15 (0.76–1.7)

Confessional hospital
59
35.75
106
64.24
168
43.42
1

Paucipara: 1-2 deliveries; multipara: 3–5 deliveries; grand multipara: more than 5 deliveries; ANC: antenatal consultations.

3.1. Sociodemographic and Obstetrical Characteristics of Participants according to the Number of Doses of TTV

As shown in Table 1, health facility (0,014), marital status (0,002), parity (<0.0001), number of antenatal consultations during the last pregnancy (<0.0001), and health facility where ANC was attended (<0.0001) were all significantly associated with the noncompletion of the 3rd dose of TTV. There was no statistically significant association between the noncompletion of 3rd dose of TTV and profession as well as level of education ( values of 0.278 and 0.676, respectively).

3.2. Knowledge of Participants on Tetanus according to the Number of TTV

As shown in Table 2, awareness on the existence of tetanus, knowledge of the recommended dose for protection, being informed on the necessity to receive a third dose of TTV during their antenatal consultations, attendance of postnatal consultation, and being the person accompanying baby for vaccination were all significantly associated with the noncompletion of the third dose of TTV ( value of <0.0001). Awareness of the disease on the other hand was not significantly associated with the noncompletion of the third dose of TTV ( value of 0.271).

Table 2: Knowledge of participants on tetanus according to the number of doses of TTV.

Variables
Number of doses of TTV
OR (95% CI)
value

<three doses
≥three doses
Total

N = 172

N = 208

N = 380

n
%
n
%
n
%

Have you ever heard of tetanus?

0.271

No
1
0.58
0
0
1
0.3
—

Yes
171
99.42
208
100
379
99.7
1

Awareness of the existence of TTV

<0.0001

No
14
8.14
0
0
14
3.7
3.37 (1.88–5.69)

Yes
158
91.86
208
100
366
96.3
1

Vaccinated against tetanus?

<0.0001

No
17
9.88
0
0
17
4.5
—

Yes
155
99 .11
208
100
363
95.5
1

Knowledge of the recommended doses for definite protections

<0.0001

No
114
66.28
70
33.65
184
48.7
3,87(2.52–5.94)

Yes
57
33.72
137
66.34
194
51.3
1

Information on TT3 during antenatal consultations

<0.0001

No
124
58.18
186
41.87
310
81.57
3.37 (1.88–5.69)

Yes
50
29.44
20
30.55
70
18.43
1

Postnatal consultation

<0.0001

No
132
70.96
54
29.03
186
48.94
9.43 (5.37–15.0)

Yes
40
20.61
154
79.38
194
51.05
1

Who accompanies the baby for vaccination?

<0.0001

Someone else
120
69,8
194
93,3
314
82.6
17.76 (6.9–645.7)

me
52
30,2
14
6,7
66
17.4
1

3.3. Adjusted Effects of Factors Influencing the Number of Doses of TTV

When all significant factors above were adjusted for each other’s effect, it was noted that three of the factors remained independently associated with the noncompletion of the third dose of TTV (Table 3). Nonattendance of postnatal consultation (aOR: 6.75 CI = 3.98–11.49, ), being single (aOR: 1.87 CI = 1.05–3.3, ), and not being the person who accompanies the baby for vaccination (aOR: 3.85 CI = 1.84–8.05, ) were all significantly associated with not completing the third dose of TTV. Therefore, compared to married women, single women were almost twofold not liable to receive the third dose of TTV. Women who did not attend postnatal consultation were 6.7 times more liable of not receiving the third dose of TTV compared to women who attended postnatal consultation. Furthermore, as compared to women who accompanied their babies for vaccination, women who did not accompany their babies for vaccination were almost four times more liable not to receive the third dose of TTV.

Table 3: Adjusted effects of factors influencing the number of doses of TTV.

Variables
Number of doses of TTV
aOR (95% CI)
value

<three doses
≥three doses

N = 172
N = 208

n
%
n
%

Health facilities

0.296

District hospital
97
51.6
91
48.4
0.58 (0.223–1.5)

St. Vincent hospital
75
39.06
117
60.94
1

Age group

0.441

≤19
8
61.5
5
38.4
1.62 (0.12–8.3)

20–25
81
55.48
65
44.5
1.26 (0.46–3.48)

26–35
71
38.17
115
61.83
0.79 (0.296–2.2)

≥36
12
34.28
23
65.7
1

Marital status

0.034

Single
70
61.4
44
38.6
1.87 (1.05–3.3)

Married
103
38.7
164
61.3
1

Postnatal consultation

<0.0001

No
132
70.96
54
29.03
6.75 (3.98–11.49)

Yes
40
20.61
154
79.38
1

Health facility where antenatal consultations were done

0.088

Integrated health center
11
68.75
5
31.25
3.33 (0.7–14.28)

Private health center
25
71.42
10
28.57
1.25 (0.41–3.75)

District hospital
77
47.23
86
52.77
3,43 (1.23–9.51)

Confessional hospital
59
35.75
106
64.24
1

Number of antenatal consultations during the last pregnancy

0.116

≤2
35
79.54
9
20.45
2.17 (0.88–0.57)

≥3
137
40.77
199
59.22
1

Information on TT3 during antenatal consultations

0.376

No
124
58.18
186
41.87
1.43 (0.64–3.18)

Yes
50
29.44
22
30.55
1

RDV for TT3 written on the hospital booklet

0.101

I do not know
23
71.87
9
28.12
2.72 (0.73–7.8)

No
31
75.6
10
24.39
2.09 (0.73–5.4)

Yes
118
38.4
189
61.5
1

Who accompanies the baby for vaccination?

<0.0001

Someone else
120
69.8
194
93.3
3.85 (1.84–8.049)

Myself
52
30.2
14
6.7
1

4. Discussion

Neonatal tetanus remains a public health problem in developing countries despite being a disease evitable by vaccination. This challenge in the elimination of tetanus transmission from mother to child is due to noncompletion of vaccination. This study was thus implemented to determine the noncompletion rate of TTV as well as identify independently associated factors in the context of Dschang Health District.

4.1. Noncompletion Rate of the 3rd Dose of TTV

Women who were never vaccinated accounted for 4.5% in our sample. This result is lower than that of 6.1% found in Benin by Togora et al. in 2013 [4]. His study however was carried out in different context and concerned mainly the completion of the second dose of TTV. It could also be possible that with time women became more aware and were advised to start tetanus vaccination which thus could justify the drop in percentage of those never vaccinated for tetanus. It was also noted that 172 (45.26%) had received less than three doses of TTV. In the literature, we did not find any studies on the noncompletion of the third dose of TTV to compare with our results. However, several authors have studied the completion of the second dose of TTV. Our rate of 45.26% noncompletion in the third dose of TTV is lower than those found for the noncompletion of the second dose of TTV which were 66.7% by Hamadoun et al. in Mali in 2006 [7], 61.7% by Togora et al. in Benin in 2013 [4, 8], and 49.3% by Talanie et al. in Congo in 2015 [9]. We believe that the above noncompletion rate is pretty high thus justifying the need to educate women about the importance of getting the third dose of TTV after delivery.

4.2. Socioeconomic and Obstetrical Characteristics of Pregnant Women Who Have Not Received the Third Dose of TTV

There was no difference between age groups in our study (Table 1). This is different from the result found by Hamadoun et al. where the 14–23 yrs age group was the most represented. This difference can be explained by the fact that we excluded nulliparous women in our study contrary to their study where all women in childbearing age were included [7, 8].

Married women were 2.43 times more likely to have received the 3rd dose of TTV and more than those who were single. This could be due to the material and psychosocial support given to the married woman. This result is close to that of Togora et al. who found in 2013 that married women were 5.33 times more likely to have good coverage in second dose of TTV and more than those who are single. This result justifies the need to encourage men to support spouses in their health and to encourage unmarried women to meet their vaccination schedule.

All women had at least one antenatal consultation during their last pregnancy. This is different from the result obtained by Hamadoun et al., who found in 2006 in Mali that the number of women who did not have antenatal consultation was 10.3% [7]. This rate of attendance of antenatal consultation could be explained by the fact that our study was conducted in an urban area where women are better informed and homes are usually close to the hospital. This result obtained by our study is a proof of the effectiveness of antenatal consultation services in our health facilities.

We found that 48.7% of women did not know the maximum dose of TTV needed to be protected. Hamadoun et al. found 61.8% [7]. This difference could be explained by the communication which may be better in our context [7]. It is therefore important to emphasize the awareness of this disease and the means of prevention.

In our study, the level of instruction had no effect on vaccination status. In contrary, Hamadoun et al. [7] showed that the more the women are educated, the better they are vaccinated. The same observation was made in the 2010–11 Senegal Demographic and Health and Multiple Cluster Indicator [10] where the birth protection level of mothers of medium or higher level was 68% compared to 62% of mothers not attending school.

4.3. Factors Influencing the Noncompletion of the 3rd Dose of Tetanus Toxoid Vaccine in Pregnant Women

The first factor associated with noncompletion of tetanus vaccine was “not going to postnatal consultation” (aOR = 6.75 CI: 3.98–11.49, ). This could be due to the fact that the 3rd dose of TTV that is done six months after the second (usually after giving birth) is not respected by these women as they think the vaccine is made for the pregnant woman only. By going to a postnatal consultation, they are exposed to the caregivers who explain to them and remind them of the need to get vaccinated. We did not find any studies in the literature with an association between postnatal consultation and TTV.

The fact of not always accompanying their baby in vaccination was also associated with noncompletion of the 3rd dose of TTV (aOR = 3784 IC: 1.803–7.942, ). This can be explained by the fact that, during the vaccination of the baby, the women are more educated and reminded about the necessity of the vaccine. Women who forgot their TTV appointment or who thought that the TTV was only for the pregnant women can be reminded and subsequently be vaccinated.

The above two factors justify the need to educate women on the importance of going for postnatal consultation as well as accompanying their own children for vaccination thus giving caregivers the opportunity to remind them of their own tetanus vaccination appointment and subsequently following them up to ensure they respect it.

Contrary to our results, authors have not found an association between accompanying the baby in vaccination and completion of the third dose of TTV. This is the case of Togora et al. who rather found an association between the number of antenatal consultations, the knowledge of the vaccination schedule, the use of radio and television at least once a week, marital status, profession, fear of side reactions (no/yes), and explanation of the vaccination schedule by the provider to be associated with coverage of the second dose of TTV [4, 7, 8, 11].

Lastly our study found an association between noncompletion of the third dose of TTV and marital status where single mothers had a higher chance of not completing the third dose of TTV. A possible explanation for this could be that single mothers especially those who had undesired pregnancies will not have the social support as well as the financial means and thus would find it difficult to go back to hospital for postnatal consultation in general and the third dose TTV in particular. It is also worth noting that factors like place of antenatal consultations, number of antenatal consultations during the last pregnancy, being informed about the third dose of TTV during the antenatal consultation, and the appointment for the third dose of TTV on the notebook were identified with the bivariate logistic regression analysis but when adjusted for all other identified factors, they were no more statistically significant. All the above independent and/or potential factors were identified by Kalac and Yalc [13], Painvin et al., Talani et al. [9] to be associated with completion of the second dose of TTV.

4.4. Limitations of the Study

The study was conducted in two health facilities, all in the urban area of Dschang Health District, which could lead to selection bias. Notwithstanding, the selected health facilities receive patients even from the hinterlands and from a wide cultural backgrounds which somehow gives second degree image on the reality of the situation in the health district. Also some questions required the participant to recall previous knowledge, thus the possibility of memory bias which nonetheless was minimised by acquiring some of the long term information from their hospital books if available and not insisting on an answer if participant did not remember.

5. Conclusion

The noncompletion rate of the third dose of tetanus vaccine was 45.26% which is pretty high especially if there is need to attain the optimal vaccination coverage to greatly reduce maternal and neonatal tetanus. The factors associated with the above noncompletion rate were being single, nonattendance of postnatal consultation, and not accompanying the baby for vaccination. There is thus the need to put in place strategies that will provide social support to single mothers making them able to not only look after their babies but themselves too as well as encourage women to attend postnatal consultation and to accompany their own children for vaccination, these later providing the opportunity for caregivers to inform, educate, and communicate to them about the necessity for them to respect appointment for their 3rd dose of TTV. Furthermore, tetanus vaccination could be integrated in community-based activities like outreaches so as to capture some of the women identified to have been lost to tetanus vaccination follow-up thus optimizing the overall vaccination coverage.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors’ Contributions

Florent Y fouelifack and Bruno Kenfack conceived the study and drafted and edited the manuscript. Skinner Lekelem Nguefack and Jackson Jr N. Ndenkeh conceived the study, collected and analyzed data, as well as drafted and edited the manuscript. Pierre Marie Tebeu supervised the study from its conception up to write-up and editing of the manuscript. All the authors read and approved the final manuscript submitted for publication.

Acknowledgments

The authors heartily appreciate the administration of Dschang District Hospital and “Saint Vincent de Paul” Hospital for having eased in carrying out this study as well as their teams working at the Obstetrics and Gynecology Units for their support during data collection. Sincere thanks equally go to all the pregnant women who enabled the authors to obtain all necessary information toward the publishing of this study.

References

UNICEF, Elimination du Tétanos Maternel et Néonatal d’ici à 2005. Stratégies Permettant D’éliminer le Tétanos et D’éviter sa Réapparition, UNICEF, Geneva, Switzerland, 2000.

UNICEF, Manuel D’application Pratique Pour L’élimination du Tétanos Néonatal, UNICEF, Geneva, Switzerland, 1999.

UNICEF, Eliminer durablement du tétanos maternel et néonatal. Plan stratégique 2012–2015, UNICEF, Geneva, Switzerland, 2012.

M. Togora, A. Kpozéhouen, J. Saizounou, and L. Sossa C Ouegraogo, “Facteurs associes a la faible couverture en vaccin antitetanique chez les femmes enceintes dans la zone sanitaire de zogbodomey-Bohicon-Zakpota au Benin,” Le Mali Médical, vol. 29, no. 3, pp. 45–48, 2014.

Institut national de Statistiques du Cameroun, “Enquête démographique et de Santé et à indicateurs multiples,” Tech. Rep., Institut national de Statistiques du Cameroun, Calverton, MD, USA, 2011, Rapport Préliminaire.

M. Vouking, C. Evina, and L. Mbuagbaw, “Vaccins chez les femmes pour la prévention du tétanos néonatal,” CDBS, vol. 1–3, 2015.

S. Hamadoun, S. Assa, D. Zeinabou, S. Yaya, and D. Haoua, “Vaccination antitetanique des femmes en age de procreer a Bamako au Mali,” Mali Medical, vol. 31, no. 3, pp. 20–25, 2016.

M. Naeem, M. Khan, S. Abbas et al., “Coverage and factors associated with tetanus toxoid vaccination among married women of reproductive age: a cross sectional study in Peshawar,” Journal of Ayub Medical College, Abbottabad: JAMC, vol. 22, no. 3, pp. 136–140, 2010.

P. Talani, H. Mayanda, and F. Yala, “Les occasions de vaccination manquées à Brazzaville,” Santé Publique., vol. 2115, no. 1, pp. 121-122, 2000.

National Agency of Statistics and ICF International, 2010-11 Senegal Demographic and Health and Multiple Indicators Survey: Key Findings, ANSD and ICF International, Calverton, MD, USA, 2012.

D. Hamidou, Evaluation de la couverture vaccinale chez les enfants âgés de 12 à 23 mois et les mères d ’ enfants âgés de 0 à 11 mois en commune V du district de Bamako en 2007, Thèse de Doctorat en Mèdecine Générale, Université de Bamako, Bamako, France, 2009.

S. Kalac and M. Yalc, “Missed opportunities for tetanus vaccination in pregnant women , and factors associated with seropositivity,” Public Health, vol. 118, pp. 377–382, 2004.

C. Painvin, M. Schlumberger, D. B. Chhem, D. Savannarom, P. Phong, and S. Gilberg, “Impact positif d’un documentaire vidéo-TV sur la vaccination antitétanique des femmes au Cambodge et causes de non-vaccination,” Bulletin de la Société de pathologie exotique, vol. 104, no. 1, pp. 29–37, 2011.